The MECP2 Consortium is a dynamic collaboration between the laboratories of three distinguished scientists, Adrian Bird, Michael Greenberg and Gail Mandel.

Reference:
MECP2 Consortium

Abstract:
n.a

Made possible by a $1 million gift by RSRT Trustee Anthony Schoener and his wife Kathy, the Consortium was formed to definitively determine how this complex protein, MeCP2, functions and exerts its powerful influence on the human brain. Deep knowledge of its structure and roles in neurological development and maintenance will inform the design of rational treatments for disorders caused by abnormalities in this protein.

PROJECT DETAILS 

beginning: 2011.

end: 2014.

Country of research: United Kingdom

Counry of funding source: United States

Funding organization: Rett Syndrome Research Trust

Financing: PRIVATE FUNDERS – 1 326 158 €

hyperlink

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close